
|Articles|October 8, 2007
Latebreakers: FDA bill draws widespread approval
Pharmacy and consumer groups approve of new FDA bill that will track drug safety after approval and speed some generic drugs to market.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Pharmacists Want Prescribing Authority With Proper Training, Support
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























